Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Miola

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Immunopharmacology|September 1, 1989
Natural killer activity in hyperprolactinemic patientsL Matera, E Ciccarelli, A Cesano, et al.
Clinical Endocrinology|February 1, 1994
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemiaE Ciccarelli, S Grottoli, C Miola, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptineE Ciccarelli, C Miola, S Grottoli, et al.
Fertility and Sterility|December 1, 1989
Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemiaE Ciccarelli, C Miola, T Avataneo, et al.
Clinical Endocrinology|May 1, 1990
Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomyE Ciccarelli, E Ghigo, C Miola, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1992
Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitusV Martina, C Miola, M Maccario, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1989
Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patientsE Ciccarelli, M Giusti, C Miola, et al.
Metabolism: Clinical and Experimental|September 1, 1992
Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in manE Ghigo, C Miola, G Aimaretti, et al.
The British Journal of Dermatology|June 5, 2018
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trialA C Miola, E R Ferreira, T R R Lima, et al.
International Journal of Dermatology|October 19, 2023
Association between calcium channel blockers and the severity of actinic keratosis on face and scalp: a cross-sectional studyIngrid S Gioppo, Ivanka M de Castro Martins, Stefany S Santos, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Immunopharmacology|September 1, 1989
Natural killer activity in hyperprolactinemic patientsL Matera, E Ciccarelli, A Cesano, et al.
Clinical Endocrinology|February 1, 1994
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemiaE Ciccarelli, S Grottoli, C Miola, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptineE Ciccarelli, C Miola, S Grottoli, et al.
Fertility and Sterility|December 1, 1989
Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemiaE Ciccarelli, C Miola, T Avataneo, et al.
Clinical Endocrinology|May 1, 1990
Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomyE Ciccarelli, E Ghigo, C Miola, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1992
Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitusV Martina, C Miola, M Maccario, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1989
Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patientsE Ciccarelli, M Giusti, C Miola, et al.
Metabolism: Clinical and Experimental|September 1, 1992
Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in manE Ghigo, C Miola, G Aimaretti, et al.
The British Journal of Dermatology|June 5, 2018
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trialA C Miola, E R Ferreira, T R R Lima, et al.
International Journal of Dermatology|October 19, 2023
Association between calcium channel blockers and the severity of actinic keratosis on face and scalp: a cross-sectional studyIngrid S Gioppo, Ivanka M de Castro Martins, Stefany S Santos, et al.
Pageof 2